Condoleezza Rice puts IRs in the spotlight
In 2002, the Society of Interventional Radiology launched a campaign to draw attention to uterine fibroid embolization. Last November, the procedure received national exposure following Secretary-of-State-designate Condoleezza Rice's successful intervention.
In 2002, the Society of Interventional Radiology launched a campaign to draw attention to uterine fibroid embolization. Last November, the procedure received national exposure following Secretary-of-State-designate Condoleezza Rice's successful intervention.
Dr. James Spies, chief of radiology at Georgetown University Hospital and a noted expert on UFE, performed the procedure.
"That such a prominent person would review the choices available to her and prefer embolization helps other women to feel comfortable with considering it and their physicians to consider offering it as an option," Spies said.
The treatment proceeded smoothly with no complications, and Rice returned home after an overnight stay in the hospital. Studies have consistently shown UFE to be effective when compared with both myomectomy and hysterectomy, and it has a short recovery time.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
